✦ LIBER ✦

P500 Fecal loss of infliximab as a cause of lack of response in severe inflammatory bowel disease

✍ Scribed by Brandse, J.F.; Wildenberg, M.E.; de Bruyn, J.R.; Wolbink, G.; Lowenberg, M.; Ponsioen, C.Y.; van den Brink, G.R.; D'Haens, G.R.A.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

157 Fecal Loss of Infliximab As a Cause

✍ Brandse, Johannan F; Wildenberg, Manon; de Bruyn, Jessica R.; Wolbink, Gert-Jan; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 433 KB

P222 Fecal calprotectin as a marker of s

✍ Dolinsek, J.; Riznik, P.; Sabath, L.; Micetic-Turk, D. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 52 KB

P387 Persistence of antibodies to inflix

✍ Leclerc, M.; Marotte, H.; Paul, S.; Del Tedesco, E.; Gonzalo, P.; Phelip, J.M.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 66 KB

Back to the Beginning: Restarting Inflix

✍ Yarur, Andres J.; Abreu, Maria T. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Role of fecal calprotectin as a biomarke

✍ Michael R. Konikoff; Lee A. Denson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Sa1257 Persistence of Antibodies to Infl

✍ Leclerc, Manon; Marotte, Hubert; Paul, Stephane; Del Tedesco, Emilie; Phelip, Je 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 231 KB